BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

871 related articles for article (PubMed ID: 16105257)

  • 1. Assessment of driving capability through the use of clinical and psychomotor tests in relation to blood cannabinoids levels following oral administration of 20 mg dronabinol or of a cannabis decoction made with 20 or 60 mg Delta9-THC.
    Ménétrey A; Augsburger M; Favrat B; Pin MA; Rothuizen LE; Appenzeller M; Buclin T; Mangin P; Giroud C
    J Anal Toxicol; 2005; 29(5):327-38. PubMed ID: 16105257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of oral cannabis and dronabinol on driving capacity].
    Giroud C; Augsburger M; Favrat B; Menetrey A; Pin MA; Rothuizen LE; Appenzeller M; Buclin T; Mathieu S; Castella V; Hazekamp A; Mangin P
    Ann Pharm Fr; 2006 May; 64(3):161-72. PubMed ID: 16710114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delta(9)-tetrahydrocannabinol, 11-hydroxy-delta(9)-tetrahydrocannabinol and 11-nor-9-carboxy-delta(9)-tetrahydrocannabinol in human plasma after controlled oral administration of cannabinoids.
    Goodwin RS; Gustafson RA; Barnes A; Nebro W; Moolchan ET; Huestis MA
    Ther Drug Monit; 2006 Aug; 28(4):545-51. PubMed ID: 16885723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating time of last oral ingestion of cannabis from plasma THC and THCCOOH concentrations.
    Huestis MA; Elsohly M; Nebro W; Barnes A; Gustafson RA; Smith ML
    Ther Drug Monit; 2006 Aug; 28(4):540-4. PubMed ID: 16885722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delta(9)-THC, 11-OH-Delta(9)-THC and Delta(9)-THCCOOH plasma or serum to whole blood concentrations distribution ratios in blood samples taken from living and dead people.
    Giroud C; Ménétrey A; Augsburger M; Buclin T; Sanchez-Mazas P; Mangin P
    Forensic Sci Int; 2001 Dec; 123(2-3):159-64. PubMed ID: 11728742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Driving Under the Influence of Marijuana Versus Driving and Dying Under the Influence of Marijuana: A Comparison of Blood Concentrations of Δ9-Tetrahydrocannabinol, 11-Hydroxy-Δ9-Tetrahydrocannabinol, 11-Nor-9-Carboxy-Δ9-Tetrahydrocannabinol and Other Cannabinoids in Arrested Drivers Versus Deceased Drivers.
    Lemos NP; San Nicolas AC; Volk JA; Ingle EA; Williams CM
    J Anal Toxicol; 2015 Oct; 39(8):588-601. PubMed ID: 26378132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma cannabinoid concentrations during dronabinol pharmacotherapy for cannabis dependence.
    Milman G; Bergamaschi MM; Lee D; Mendu DR; Barnes AJ; Vandrey R; Huestis MA
    Ther Drug Monit; 2014 Apr; 36(2):218-24. PubMed ID: 24067260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended plasma cannabinoid excretion in chronic frequent cannabis smokers during sustained abstinence and correlation with psychomotor performance.
    Karschner EL; Swortwood MJ; Hirvonen J; Goodwin RS; Bosker WM; Ramaekers JG; Huestis MA
    Drug Test Anal; 2016 Jul; 8(7):682-9. PubMed ID: 26097154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Cannabidiol and Δ9-Tetrahydrocannabinol on Driving Performance: A Randomized Clinical Trial.
    Arkell TR; Vinckenbosch F; Kevin RC; Theunissen EL; McGregor IS; Ramaekers JG
    JAMA; 2020 Dec; 324(21):2177-2186. PubMed ID: 33258890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychomotor performance in relation to acute oral administration of Delta9-tetrahydrocannabinol and standardized cannabis extract in healthy human subjects.
    Roser P; Gallinat J; Weinberg G; Juckel G; Gorynia I; Stadelmann AM
    Eur Arch Psychiatry Clin Neurosci; 2009 Aug; 259(5):284-92. PubMed ID: 19224107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous and sensitive analysis of THC, 11-OH-THC, THC-COOH, CBD, and CBN by GC-MS in plasma after oral application of small doses of THC and cannabis extract.
    Nadulski T; Sporkert F; Schnelle M; Stadelmann AM; Roser P; Schefter T; Pragst F
    J Anal Toxicol; 2005; 29(8):782-9. PubMed ID: 16356335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognition and motor control as a function of Delta9-THC concentration in serum and oral fluid: limits of impairment.
    Ramaekers JG; Moeller MR; van Ruitenbeek P; Theunissen EL; Schneider E; Kauert G
    Drug Alcohol Depend; 2006 Nov; 85(2):114-22. PubMed ID: 16723194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis effects on driving lateral control with and without alcohol.
    Hartman RL; Brown TL; Milavetz G; Spurgin A; Pierce RS; Gorelick DA; Gaffney G; Huestis MA
    Drug Alcohol Depend; 2015 Sep; 154():25-37. PubMed ID: 26144593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delta-9-tetrahydrocannabinol (THC) serum concentrations and pharmacological effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg THC.
    Hunault CC; Mensinga TT; de Vries I; Kelholt-Dijkman HH; Hoek J; Kruidenier M; Leenders ME; Meulenbelt J
    Psychopharmacology (Berl); 2008 Dec; 201(2):171-81. PubMed ID: 18695931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Time profile of serum THC levels in occasional and chronic marihuana smokers after acute drog use - implication for drivind motor vehicles].
    Balíková M; Hložek T; Páleníček T; Tylš F; Viktorinová M; Melicher T; Androvičová R; Tomíček P; Roman M; Horáček J
    Soud Lek; 2014; 59(1):2-6. PubMed ID: 24625019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of cannabinoid concentrations in oral fluid and whole blood between occasional and regular cannabis smokers prior to and after smoking a cannabis joint.
    Fabritius M; Chtioui H; Battistella G; Annoni JM; Dao K; Favrat B; Fornari E; Lauer E; Maeder P; Giroud C
    Anal Bioanal Chem; 2013 Dec; 405(30):9791-803. PubMed ID: 24202191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmortem redistribution of Δ9-tetrahydrocannabinol (THC), 11-hydroxy-THC (11-OH-THC), and 11-nor-9-carboxy-THC (THCCOOH).
    Holland MG; Schwope DM; Stoppacher R; Gillen SB; Huestis MA
    Forensic Sci Int; 2011 Oct; 212(1-3):247-51. PubMed ID: 21764230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of Δ9-tetrahydrocannabinolic acid A (Δ9-THCA-A) in whole blood and plasma by LC-MS/MS and application in authentic samples from drivers suspected of driving under the influence of cannabis.
    Raikos N; Schmid H; Nussbaumer S; Ambach L; Lanz S; Längin A; König S; Roth N; Auwärter V; Weinmann W
    Forensic Sci Int; 2014 Oct; 243():130-6. PubMed ID: 25173986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive model accuracy in estimating last Δ9-tetrahydrocannabinol (THC) intake from plasma and whole blood cannabinoid concentrations in chronic, daily cannabis smokers administered subchronic oral THC.
    Karschner EL; Schwope DM; Schwilke EW; Goodwin RS; Kelly DL; Gorelick DA; Huestis MA
    Drug Alcohol Depend; 2012 Oct; 125(3):313-9. PubMed ID: 22464363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana.
    Huestis MA; Henningfield JE; Cone EJ
    J Anal Toxicol; 1992; 16(5):276-82. PubMed ID: 1338215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.